You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Disease Progression

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia, Richter's Transformation Trial in Boston (Glofitamab, Obinutuzumab, Polatuzumab Vedotin)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Richter's Transformation
  • Boston, Massachusetts
  • +1 more
Sep 12, 2023

HER2-positive Advanced Solid Tumors Trial in Beijing, Guangzhou, Tianjin (SPH5030 tablets)

Recruiting
  • HER2-positive Advanced Solid Tumors
  • SPH5030 tablets
  • Beijing, Beijing, China
  • +2 more
Mar 10, 2022

Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias Trial in United States (Dipraglurant)

Recruiting
  • Parkinson Disease
  • +2 more
  • Augusta, Georgia
  • +6 more
Apr 18, 2022

FLT-PET / MRI Brain Mets

Recruiting
  • Brain Metastases
  • Radionecrosis
    • Toronto, Ontario, Canada
      University Health Network
    Oct 6, 2022

    Soft Tissue Sarcoma Trial in Worldwide (Olaratumab, Doxorubicin, Placebo)

    Active, not recruiting
    Has Results
    • Soft Tissue Sarcoma
    • Duarte, California
    • +117 more
    Mar 22, 2022

    Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)

    Recruiting
    • Rectal Cancer
    • Kineret 100 MG in 0.67 ML Prefilled Syringe
    • +3 more
    • Frankfurt, Germany
      University Hospital Goethe University Frankfurt
    Aug 23, 2022

    Objective Response Rate Trial in Wuhan (GM-CSF)

    Recruiting
    • Objective Response Rate
    • Wuhan, Hubei, China
      Renmin Hospital of Wuhan University
    Feb 25, 2023

    Recurrent B Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory B Acute Lymphoblastic Leukemia

    Recruiting
    • Recurrent B Acute Lymphoblastic Leukemia
    • +3 more
    • Blinatumomab
    • +2 more
    • New Haven, Connecticut
    • +6 more
    Jul 9, 2022

    NSCLC Trial in Changsha (SHR-1701 Combined With Fluazopalil)

    Recruiting
    • Non-Small Cell Lung Cancer
    • SHR-1701 Combined With Fluazopalil
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Feb 28, 2022

    Metastatic Leiomyosarcoma, Metastatic Soft Tissue Sarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in United

    Recruiting
    • Metastatic Leiomyosarcoma
    • +10 more
    • Duarte, California
    • +4 more
    Nov 4, 2021

    Non-Hodgkin Lymphoma Trial in United States

    Active, not recruiting
    • Non-Hodgkin Lymphoma
      • Miami, Florida
      • +7 more
      Jun 23, 2022

      Breast Cancer, Triple Negative Breast Cancer, Camrelizumab Trial in Zhengzhou ((Carrelizumab + TCb) regimen, TCb regimen)

      Recruiting
      • Breast Cancer
      • +2 more
      • （Carrelizumab + TCb） regimen
      • TCb regimen
      • Zhengzhou, Henan, China
        Henan cancer hospital
      Jul 24, 2022

      Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head and Neck Carcinoma Trial in La Jolla (IPI-549)

      Recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +7 more
      • La Jolla, California
        UC San Diego Moores Cancer Center
      Jul 20, 2022

      Neuroendocrine Tumors, Carcinoid Tumors Trial in Stanford, Tampa (Pasireotide Long Acting Release (LAR))

      Active, not recruiting
      Has Results
      • Neuroendocrine Tumors
      • Carcinoid Tumors
      • Pasireotide Long Acting Release (LAR)
      • Stanford, California
      • +1 more
      Jan 11, 2022

      Gastrointestinal Cancer, Biliary Tract Cancer Trial in Taichung, Tainan, Taipei (D07001-softgel capsules)

      Terminated
      • Gastrointestinal Cancer
      • Biliary Tract Cancer
      • D07001-softgel capsules
      • Taichung, Taiwan
      • +3 more
      Aug 25, 2021

      Metastatic Colorectal Cancer Trial in France, Martinique (FOLFOX + panitumumab)

      Recruiting
      • Metastatic Colorectal Cancer
      • FOLFOX + panitumumab
      • Sainte Colombe, Lyon, France
      • +45 more
      Mar 23, 2022

      Metastatic Colorectal Cancer Trial in Providence (Dose level 1 ONC201 625mg, Dose level 2 ONC201 500mg, Dose level 3 ONC201

      Terminated
      Has Results
      • Metastatic Colorectal Cancer
      • Dose level 1 ONC201 625mg
      • +2 more
      • Providence, Rhode Island
        Lifespan Cancer Institute: The Miriam and Rhode Island Hospitals
      May 25, 2022

      Liposarcoma, Dedifferentiated Trial in Worldwide (BI 907828, Doxorubicin)

      Recruiting
      • Liposarcoma, Dedifferentiated
      • Birmingham, Alabama
      • +131 more
      Feb 2, 2023

      Advanced Solid Tumor Malignancy Trial in Ghent (KBA1412, Pembrolizumab)

      Recruiting
      • Advanced Solid Tumor Malignancy
      • Ghent, Belgium
        University Hospital Ghent
      Aug 11, 2022

      Predictors and Prognostic Factors of Myasthenia Gravis Outcome

      Recruiting
      • Myasthenia Gravis
      • +11 more
      • Drug treatment of myasthenia gravis and treatment of crisis
      • Assiut, Egypt
        Assiut University
      Feb 22, 2022

      NSCLC Trial in Chicago, Hershey (sapacitabine)

      Terminated
      • Non-small Cell Lung Cancer
      • Chicago, Illinois
      • +1 more
      Dec 7, 2021

      Relapsed/Refractory Multiple Myeloma Trial in United States (UCARTCS1A)

      Recruiting
      • Relapsed/Refractory Multiple Myeloma
      • UCARTCS1A
      • San Francisco, California
      • +4 more
      Nov 11, 2021

      Advanced Solid Tumor Trial in Portland (HS-110 (viagenpumatucel-L), HS-130)

      Active, not recruiting
      • Advanced Solid Tumor
      • HS-110 (viagenpumatucel-L)
      • HS-130
      • Portland, Oregon
        Providence Portland Medical Center
      Feb 2, 2022

      Leukemia, Myeloid, Acute Trial in Chengdu (Chidamide)

      Recruiting
      • Leukemia, Myeloid, Acute
      • Chengdu, Sichuan, China
        West China Hospital of Sichuan University
      Dec 27, 2022

      Breast Cancer Trial in Worldwide (Capecitabine, Exemestane, Everolimus)

      Completed
      Has Results
      • Breast Cancer
      • Los Angeles, California
      • +82 more
      Feb 19, 2021